NewEdge Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$498K	Buy	52,326 +2,285	+5%	+$17.7K	﹤0.01%	1993
2025 Q4	$390K	Buy	+50,041	New	+$362K	﹤0.01%	2140
2025 Q2	–	Sell	-11	Closed	-$83	–	3995
2025 Q1	$83	Hold	11	–	–	﹤0.01%	3833
2024 Q4	$83	Buy	+11	New	+$84	﹤0.01%	3790
2023 Q4	–	Sell	-30	Closed	-$212	–	3759
2023 Q3	$212	Hold	30	–	–	﹤0.01%	3320
2023 Q2	$211	Sell	30 -4,078	-99%	-$32.7K	﹤0.01%	3381
2023 Q1	$34.3K	Sell	4,108 -4,217	-51%	-$40.6K	﹤0.01%	2154
2022 Q4	$96	Buy	+8,325	New	+$104K	﹤0.01%	3380
2022 Q2	–	Sell	-11,495	Closed	-$187K	–	1565
2022 Q1	$187K	Sell	11,495 -1,123	-9%	-$18K	﹤0.01%	1026
2021 Q4	$175K	Sell	12,618 -1,637	-11%	-$21.7K	﹤0.01%	1538
2021 Q3	$205K	Buy	14,255 +1,964	+16%	+$31K	0.01%	1047
2021 Q2	$194K	Sell	12,291 -115	-0.9%	-$1.56K	0.01%	1056
2021 Q1	$126K	Buy	+12,406	New	+$128K	﹤0.01%	976
2020 Q4	–	Sell	-24,000	Closed	-$82K	–	981
2020 Q3	$82K	Buy	+24,000	New	+$103K	﹤0.01%	875